Page last updated: 2024-08-24

marbofloxacin and Escherichia coli Infections

marbofloxacin has been researched along with Escherichia coli Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balsliemke, J; Carl, A; Eisenberger, D; Kämpf, P; Nickel, S; Schulze, G; Valenza, G1
Ding, H; Gu, X; Shen, X; Wang, L; Zeng, D; Zeng, Z1
Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G1
Bousquet-Mélou, A; Ferran, AA; Kesteman, AS; Toutain, PL1
Choi, MJ; Damte, D; Gebru, E; Lee, SJ; Park, SC1
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC1
Gicquel-Bruneau, M; Laurentie, M; Pellet, T; Sanders, P1
Fink-Gremmels, J; Haritova, AM; Lashev, LD; Parvanov, PR; Rusenova, NV1
Concordet, D; Regnier, A; Schneider, M; Toutain, PL1

Other Studies

9 other study(ies) available for marbofloxacin and Escherichia coli Infections

ArticleYear
Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Milk Samples of Dairy Cows with Mastitis in Bavaria, Germany.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cattle; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Germany; Mastitis, Bovine; Milk; Multilocus Sequence Typing

2018
Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli.
    Journal of veterinary pharmacology and therapeutics, 2013, Volume: 36, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Chickens; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Mycoplasma gallisepticum; Mycoplasma Infections; Poultry Diseases; Tissue Distribution

2013
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
    Transboundary and emerging diseases, 2015, Volume: 62, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol

2015
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Thigh

2009
Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 10

    Topics: Animals; Anti-Bacterial Agents; DNA, Bacterial; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Selection, Genetic; Sequence Analysis, DNA; Time Factors

2011
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
    Veterinary microbiology, 2012, Jan-27, Volume: 154, Issue:3-4

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation

2012
Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
    Research in veterinary science, 2006, Volume: 80, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Poultry Diseases; Quinolones; Swine; Swine Diseases; Turkeys

2006
Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Injections, Intravenous; Male; Microbial Sensitivity Tests; Quinolones; Serum Bactericidal Test; Turkeys

2006
Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
    American journal of veterinary research, 2008, Volume: 69, Issue:3

    Topics: Animals; Anti-Infective Agents; Aqueous Humor; Area Under Curve; Disease Models, Animal; Dog Diseases; Dogs; Endophthalmitis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones; Rabbits; Vitreous Body

2008